Life Scientists as a Percentage of All Occupations This indicator represents the percentage of life scientists in a state’s workforce. Life scientists are identified from standard occupational codes that include agricultural and food scientists, biological scientists, conservation scientists and foresters, medical scientists, and postsecondary teachers in these fields. A high share of life scientists in a state’s workforce could indicate a robust cluster of life sciences industries such as pharmaceutical and medicine manufacturing. States in the top quartile for this indicator also tend to contain agriculture-intensive industries.
The biotech economy continues its expansion and shows no sign of slowing in 2022. On this webinar you’ll hear from several biomanufacturing leaders from various sectors of the field to talk about the biomanufacturing roles at their company and what they look for when hiring for their teams.
Around 200 attendees joined BioBuzz’s first gathering since pre-COVID at Brookeville Beer Farm last week, reveling in the feeling of being face-to-face with other community members of the Biohealth Capital Region after a year and a half of Zoom meetings. The event, which CRB sponsored, highlighted the importance of getting back together as a community.
Whether you’re just starting your biotech career or have a long tenure at your current employer, deciding when to make a career move can be extremely stressful and challenging, especially in a chaotic job market disrupted and reshaped by a global pandemic.
CRB, a global architecture, engineering, construction (AEC) and consulting firm, with a major office in Rockville, Maryland, has been on the cutting edge of the biotechnology real estate business for over 35 years. Established in 2014 with just 8 people, over the past 2 years CRB’s Rockville office has grown from 50 employees to over 90, says Ben Skowronski, office lead. And they are still growing!
The pandemic changed everything. We live differently, behave differently, and have come to appreciate the little things we might have taken for granted before COVID-19 took hold in the BioHealth Capital Region (BHCR).
In an incredibly short time, Gaithersburg, Maryland’s Novavax has advanced its SARS-CoV-2 vaccine candidate into Phase III trials and received FDA fast track designation, putting its vaccine very close to potential FDA approval. There has been a herculean effort underway by Novavax and other companies to deliver desperately needed pandemic protection to people across the globe.
Maryland’s leading vaccine manufacturer, Emergent Biosolutions (Emergent) is a global biopharmaceutical company that has become a key player in the BioHealth Capital Region’s (BCHR) fight against COVID-19.